Acute Hypercortisolemia Exerts Depot-Specific Effects on Abdominal and Femoral Adipose Tissue Function

J Clin Endocrinol Metab. 2017 Apr 1;102(4):1091-1101. doi: 10.1210/jc.2016-3600.

Abstract

Context: Glucocorticoids have pleiotropic metabolic functions, and acute glucocorticoid excess affects fatty acid metabolism, increasing systemic lipolysis. Whether glucocorticoids exert adipose tissue depot-specific effects remains unclear.

Objective: To provide an in vivo assessment of femoral and abdominal adipose tissue responses to acute glucocorticoid administration.

Design and outcome measures: Nine healthy male volunteers were studied on two occasions, after a hydrocortisone infusion (0.2 mg/kg/min for 14 hours) and a saline infusion, respectively, given in randomized double-blind order. The subjects were studied in the fasting state and after a 75-g glucose drink with an in vivo assessment of femoral adipose tissue blood flow (ATBF) using radioactive xenon washout and of lipolysis and glucose uptake using the arteriovenous difference technique. In a separate study (same infusion design), eight additional healthy male subjects underwent assessment of fasting abdominal ATBF and lipolysis only. Lipolysis was assessed as the net release of nonesterified fatty acids (NEFAs) from femoral and abdominal subcutaneous adipose tissue.

Results: Acute hypercortisolemia significantly increased basal and postprandial ATBF in femoral adipose tissue, but the femoral net NEFA release did not change. In abdominal adipose tissue, hypercortisolemia induced substantial increases in basal ATBF and NEFA release.

Conclusions: Acute hypercortisolemia induces differential lipolysis and ATBF responses in abdominal and femoral adipose tissue, suggesting depot-specific glucocorticoid effects. Abdominal, but not femoral, adipose tissue contributes to the hypercortisolemia-induced systemic NEFA increase, with likely contributions from other adipose tissue sources and intravascular triglyceride hydrolysis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Abdomen
  • Absorptiometry, Photon
  • Adipose Tissue / drug effects*
  • Adipose Tissue / metabolism
  • Adult
  • Cushing Syndrome / chemically induced*
  • Cushing Syndrome / metabolism
  • Double-Blind Method
  • Femur
  • Humans
  • Hydrocortisone / administration & dosage*
  • Hydrocortisone / blood
  • Lipolysis / drug effects*
  • Male
  • Middle Aged
  • Subcutaneous Fat, Abdominal / drug effects*
  • Subcutaneous Fat, Abdominal / metabolism
  • Thigh
  • Young Adult

Substances

  • Hydrocortisone